AS PRFoods resolutions of the Shareholders

Udgivet den 31-12-2024  |  kl. 11:13  |  

AS PRFoods resolutions of the Shareholders adopted by the General Meeting of Shareholders of AS PRFoods on 31.12.2024 without calling a meeting

The general meeting of shareholders (the Meeting) of AS PRFoods (the Company) was held without convening a meeting in accordance with § 2991 of the Commercial Code. The voting took place via submitting the voting ballots during the period from 10.12.2024 to 31.12.2024. According to the Commercial Code, in the event of non-voting, the shareholder is deemed to have voted against the resolution. 

Following the submission of the voting ballots, the Meeting adopted the following resolutions:

Approval of 01.07.2023 - 30.06.2024 annual report

To approve the 01.07.2023 - 30.06.2024 annual report of AS PRFoods.

Voting results:

Votes Number of Votes Proportion to total votes (%)
In favour 24,446,715 63.2%
Against (did not vote) 14,236,145 36.8%
Impartial 0 0%
Total 38,682,860 100%


Covering the loss

The loss in the period 01.07.2023 - 30.06.2024 was EUR 4,673,000. To cover the loss from the profits of future periods.

Voting results:

Votes Number of Votes Proportion to total votes (%)
In favour 24,446,715 63.2%
Against (did not vote) 14,236,145 36.8%
Impartial 0 0%
Total 38,682,860 100%

The resolutions were adopted in accordance with the stipulations of the law and Company's articles of association. 

Kristjan Kotkas
AS PRFoods
Management board member
T: +372 452 1470
investor@prfoods.ee
www.prfoods.ee


\Hugin

Udgivet af: NPinvestordk

Seneste nyheder

17:55 Europa/lukning: Novo-nedtur og tvivl om tysk investeringspakke sendte indeks i knæ
17:07 Mandagens aktier: Novo-data rykkede C25 i minus - Mærsk gik frem på houthi-trussel
17:00 Mandagens obligationer: Rentefald gik i sig selv efter tysk uenighed om investeringspakke
16:46 Genmab-analytiker efter afvisning fra partner og kursfald: Det var lidt en netruller
16:26 Tesla-aktien halveret siden toppen i december
15:39 Genmab-partneren Johnson & Johnson vil ikke gøre brug af Hexabody-option
14:59 Novo-aktien dykker over 8 pct. efter svage vægttabsdata
14:41 USA/åbning: Korrektion til Nasdaq i et Wall Street præget af udsalg
13:50 Ørsted får sænket kreditvurderingen af Fitch
13:15 Musks indtog i politik kan skade Tesla vurderer Kinas personbilforening
12:58 ECB's Kazimir: Næste rentetræk bør træffes med et "åbent sind"
12:55 Mærsk-analytiker: Trusler om nye angreb i Det Røde Hav sender aktier op
12:54 USA/tendens: Rød dag i vente - Nasdaq tæt på korrektion
12:41 Novos fedmedata adskiller sig ikke nok fra konkurrentens vurderer analytiker
12:34 Renter tager ekstra dyk efter modstand mod massiv tysk investeringspakke
12:15 Novo når primære endemål i vigtigt fase 3-studie for Cagrisema
11:54 Europa/middag: Våbenaktierne vinder fortsat frem mens banksektoren står for skud
11:51 Novo når primære endemål i vigtigt fase 3-studie for Cagrisema
11:43 Obligationer/middag: Lille rentefald præger afdæmpet start på ugen
11:27 Aktier/middag: Brintselskab sendes i dybet - geopolitik lurer under overfladen